Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib HCV-RNA Kinetics in Advanced HCC
NCT01849588Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- May 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Massachusetts General Hospital. Started May 2013; status: terminated.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01849588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849588.